Category Archives: "News"

Biogen Idec and AbbVie Announce Results from Phase 3 Study Investigating Daclizumab
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple [...]
Official reports from the 2014 cooperative meeting of CMSC & ACTRIMS – 5/31/2014
CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS Saturday, May 31, 2014 Photos of the [...]
Workforce of the Future spotlighted at multiple sclerosis conference
Workforce of the Future Spotlighted at MS Conference Foundation of CMSC Presents Record Number of Scholars and Awardees (Hackensack, [...]
Genzyme’s Lemtrada resubmission accepted for review by FDA
Genzyme’s Lemtrada Resubmission Accepted for Review by FDA - Agency action expected in Q4 2014 - Cambridge, Mass. - May 30, 2014 - [...]
Data from Biogen Idec’s portfolio of multiple sclerosis therapies and pipeline featured at congresses
Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses Friday, May 30, 2014 [...]
Official reports from the 2014 cooperative meeting of CMSC & ACTRIMS – 5/30/2014
CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS Friday, May 30, 2014 Photos of the [...]
Official reports from the 2014 cooperative meeting of CMSC & ACTRIMS – 5/29/2014
CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS Thursday, May 29, 2014 Photos of the [...]
Biogen Idec announces official partnership with Sailing Sclerosis’ “Oceans of Hope”
Biogen Idec Announces Official Partnership with Sailing Sclerosis Oceans of Hope to Globally Change Perceptions of MS Wednesday, May [...]
EMD Serono data at CMSC & ACTRIMS Annual Meeting reinforces proven efficacy of rebif
EMD Serono Data at CMSC & ACTRIMS Annual Meeting Reinforces Proven Efficacy of Rebif® (interferon beta-1a) and Demonstrates Continued [...]
Media alert — grow your multiple sclerosis knowledge
Contact: Annie Scully, 201-310-9252, annie.scully@mscare.org MEDIA ALERT Grow Your MS [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM